Cargando…
Ranolazine - could an antianginal drug be used in stroke prevention?
Autores principales: | Surma, Stanisław, Romańczyk, Monika, Filipiak, Krzysztof J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168496/ https://www.ncbi.nlm.nih.gov/pubmed/35677351 http://dx.doi.org/10.1016/j.ijcrp.2022.200137 |
Ejemplares similares
-
Evinacumab – The new kid on the block. Is it important for cardiovascular prevention?
por: Surma, Stanisław, et al.
Publicado: (2021) -
Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10
por: Filipiak, Krzysztof J., et al.
Publicado: (2022) -
Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia
por: Surma, Stanisław, et al.
Publicado: (2023) -
Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021) -
Colchicine — From rheumatology to the new kid on the block: Coronary syndromes and COVID-19
por: Surma, Stanisław, et al.
Publicado: (2023)